Remlarsen

N/A

Report date: 2025/06/26 20:00:07
NME

Base Information

Drug NameRemlarsen
Drug Alias NameSynthetic microRNA29 MimicpromiR29Synthetic miR-29 MimicpromiR-29MRG-201 +[7] 
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > microRNA
Mechanisms of ActionCollagen inhibitors
TargetsCollagen
Therapy Area/IndicationsKeloid
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited States
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesUniversity of Texas Southwestern Medical Center
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesViridian Therapeutics Inc
Active IndicationsN/A
Inactive IndicationsKeloid

Other Information

ATC CodeN/A
Related LinksN/A